These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 2379562
21. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a". Lounes KC, Soria C, Mirshahi SS, Desvignes P, Mirshahi M, Bertrand O, Bonnet P, Koopman J, Soria J. Blood; 2000 Nov 15; 96(10):3473-9. PubMed ID: 11071644 [Abstract] [Full Text] [Related]
22. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization. Tanaka H, Terasawa F, Ito T, Tokunaga S, Ishida F, Kitano K, Kiyosawa K, Okumura N. Thromb Haemost; 2001 Jan 15; 85(1):108-13. PubMed ID: 11204560 [Abstract] [Full Text] [Related]
23. Fibrinogen Seattle releases half the normal amount of fibrinopeptide B. Branson HE, Schmer G, Theodor I, Pirkle H. Acta Haematol; 1983 Jan 15; 70(4):257-63. PubMed ID: 6414212 [Abstract] [Full Text] [Related]
24. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release. Yan J, Luo M, Cheng P, Liao L, Deng X, Deng D, Lin F. Int J Hematol; 2017 Apr 15; 105(4):506-514. PubMed ID: 27933517 [Abstract] [Full Text] [Related]
27. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules. Jandrot-Perrus M, Aurousseau MH, Rabiet MJ, Josso F. Thromb Res; 1982 Sep 15; 27(6):659-70. PubMed ID: 6217586 [Abstract] [Full Text] [Related]
31. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release. Lane DA, Cuddigan B, VanRoss M, Kakkar VV. Br J Haematol; 1980 Mar 01; 44(3):483-94. PubMed ID: 6769460 [Abstract] [Full Text] [Related]
35. Novel structure elucidation strategy for genetically abnormal fibrinogens with incomplete fibrinopeptide release as applied to fibrinogen Schwarzach. Henschen A, Kehl M, Deutsch E. Hoppe Seylers Z Physiol Chem; 1983 Dec 01; 364(12):1747-51. PubMed ID: 6667926 [Abstract] [Full Text] [Related]
36. Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis. Ebert RF, Bell WR. Proc Natl Acad Sci U S A; 1983 Dec 01; 80(23):7318-22. PubMed ID: 6580646 [Abstract] [Full Text] [Related]
37. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia. Furlan M, Bögli C, Hofer A, Bouvier CA, de Moerloose P. Blood Coagul Fibrinolysis; 1990 Jun 01; 1(2):139-43. PubMed ID: 2130925 [Abstract] [Full Text] [Related]
38. Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His. Luo M, Deng D, Xiang L, Cheng P, Liao L, Deng X, Yan J, Lin F. Medicine (Baltimore); 2016 Sep 01; 95(39):e4864. PubMed ID: 27684817 [Abstract] [Full Text] [Related]
39. Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality. Andes WA, Chavin SI, Beltran G, Stuckey WJ. Thromb Res; 2016 Sep 01; 25(1-2):41-50. PubMed ID: 6801812 [Abstract] [Full Text] [Related]